EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidemiology and Clinical Impact of Clonal Hematopoiesis in People With HIV

Valeriia Timonina iD, Konstantin Popadin, Mariam Ait Oumelloul, Alexandra Calmy, Matthias Cavassini iD, Gioele Capoferri iD, Huldrych F Günthard iD, Laura N Walti, Patrick Schmid, Philip E Tarr iD, Christian W Thorball iD, Alexander G Bick und 2 weitere

The Journal of Infectious Diseases · 16.11.2026 · 234 (5) · e1170-e1181

DOI: 10.1093/infdis/jiag393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 28.07.2026. Verfasst von Valeriia Timonina und 13 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Clonal Hematopoiesis, HIV Infections. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation, SHCS project, SHCS research foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clonal hematopoiesis (CH), defined by the expansion of hematopoietic cells with somatic mutations in leukemogenic genes (CH of indeterminate potential [CHIP]) or with mosaic chromosomal alterations (mCAs), is associated with aging and adverse health outcomes in the general population. Clonal hematopoiesis of indeterminate potential prevalence is higher in people with human immunodeficiency virus (PWH) than in controls. However, the full spectrum, prevalence, and clinical consequences of CH in PWH remain incompletely understood.

Methods

We assessed CHIP and mCAs in a large sample of PWH (N∼2500) from the Swiss HIV Cohort Study. Using high-depth targeted sequencing of CHIP genes and genome-wide genotyping to call mCAs, we quantified the prevalence and clone size of both CH types and investigated an association of CH with clinical variables.

Results

Clonal hematopoiesis of indeterminate potential (25% of individuals) and mCAs (16% of individuals) were common, positively correlated with age, often co-occurring (odds ratio = 1.7, P = .02 for autosomal mCAs), and associated with various clinical outcomes, including all-cause mortality (hazard ratio [HR] = 1.3, P = .02 for CHIP) and hematologic malignancies (HR = 9.4, P = .01 for the effect of CHIP on the risk of myeloid cancer; HR > 20, P < .001 for the effect of co-occurring CHIP and mCAs on the risk of lymphoid cancer). We also observed associations of CH with several proxies of inflammatory status (CD4:CD8 ratio, HIV load, late initiation of antiretroviral therapy, and toxicity of antiretroviral drugs).

Conclusions

The study provides a comprehensive assessment of the CH landscape in PWH, highlighting potential causes and consequences in this population and suggesting an interaction between CH and chronic immune activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clonal HematopoiesisHIV InfectionsHumansFemaleMaleMiddle AgedAdultSwitzerlandMutationCohort StudiesPrevalenceChromosome Aberrations

Stichwörter der Autor:innen

CHIPHIVagingclonal hematopoiesismCAs

Autor:innen und Institutionen

  • School of Life Sciences, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Host-Pathogen Genomics Group, Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Center for Mitochondrial Functional Genomics, Immanuel Kant Baltic Federal University, Kaliningrad, Russia.
  • Division of Infectious Disease, Geneva University Hospital, Geneva, Switzerland.
  • Division of Infectious Diseases, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Division of Infectious Diseases, Regional Hospital Bellinzona, Bellinzona, Switzerland.

ORCID-Profile: Valeriia Timonina, Matthias Cavassini, Gioele Capoferri, Huldrych F Günthard, Philip E Tarr, Christian W Thorball, Jacques Fellay

Förderung

  • Swiss National Science Foundation
  • SHCS project
  • SHCS research foundation

Zitieren

APA

Timonina, V., Popadin, K., Ait Oumelloul, M., Calmy, A., Cavassini, M., Capoferri, G., Günthard, H. F., Walti, L. N., Schmid, P., Tarr, P. E., Thorball, C. W., Bick, A. G., Fellay, J., & Swiss HIV Cohort Study (SHCS) (2026). Epidemiology and Clinical Impact of Clonal Hematopoiesis in People With HIV. The Journal of Infectious Diseases, 234(5), e1170-e1181. https://doi.org/10.1093/infdis/jiag393

Vancouver

Timonina V, Popadin K, Ait Oumelloul M, Calmy A, Cavassini M, Capoferri G, et al. Epidemiology and Clinical Impact of Clonal Hematopoiesis in People With HIV. The Journal of Infectious Diseases. 2026;234(5):e1170-e1181. doi:10.1093/infdis/jiag393

BibTeX
@article{Timonina2026,
  author = {Timonina, Valeriia and Popadin, Konstantin and Ait Oumelloul, Mariam and Calmy, Alexandra and Cavassini, Matthias and Capoferri, Gioele and Günthard, Huldrych F and Walti, Laura N and Schmid, Patrick and Tarr, Philip E and Thorball, Christian W and Bick, Alexander G and Fellay, Jacques and Swiss HIV Cohort Study (SHCS), Swiss HIV Cohort Study (SHCS)},
  title = {Epidemiology and Clinical Impact of Clonal Hematopoiesis in People With HIV},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  volume = {234},
  number = {5},
  pages = {e1170--e1181},
  doi = {10.1093/infdis/jiag393}
}
Kostenlos starten →